Effects of interleukin-6 on mobilization of primitive haemopoietic cells into the circulation.
De Wynter, Erika A
Coutinho, Lucia H
Scarffe, J Howard
Testa, Nydia G
AffiliationCRC Department of Medical Oncology, Christie Hospital, Manchester.
MetadataShow full item record
AbstractTwenty-seven patients with advanced adenocarcinoma were studied. Groups of three patients received interleukin-6 (IL-6) in doses ranging from 0.5 to 20 micrograms/kg by daily subcutaneous injection on days 1-7 and 22-49. Four patients received IL-6 2.5 micrograms/kg/d with GM-CSF 5 micrograms/kg/d and three patients received IL-6 2.5 micrograms/kg/d with IL-3 5 micrograms/kg/d. Circulating platelet numbers increased 1.65-fold during IL-6 treatment, in a dose-dependent fashion (P = 0.01). This increase is inferior to that expected from laboratory studies. No significant change in total WBC was seen after IL-6 alone. After treatment with IL-6, significant increases in numbers of circulating mononuclear cells (2.2-fold, P = 0.006) and GM-CFC numbers (3.2-fold, P = 0.01) were seen, but there were no changes in circulating megakaryocyte-CFC numbers. In contrast, after treatment with IL-6 and GM-CSF, larger increases in both circulating GM-CFC (20-fold, P = 0.04) and megakaryocyte-CFC numbers (18-fold, P = 0.03) were seen. Increases in blood progenitors after treatment with IL-6 and IL-3 did not achieve statistical significance. The ability of peripheral blood mononuclear cells to generate and sustain long-term haemopoiesis in vitro was similar in IL-6-treated patients to that in untreated control subjects. No significant changes in the incidence of bone marrow progenitors or their cycling status (assessed by thymidine suicide) were seen. These data suggest that IL-6 alone will not be clinically useful to mobilize blood progenitor cells in cancer patients.
CitationEffects of interleukin-6 on mobilization of primitive haemopoietic cells into the circulation. 1995, 89 (2):237-42 Br. J. Haematol.
JournalBritish Journal of Haematology
- Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cells.
- Authors: Geissler K, Peschel C, Niederwieser D, Goldschmitt J, Hladik F, Fritz A, Ohler L, Bettelheim P, Huber C, Lechner K
- Issue date: 1995 Oct
- Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combination.
- Authors: Lord BI, Testa NG, Bretti S, Chang J, Demuynck H, Coutinho L, de Campos E, Fitzsimmons L, Scarffe JH
- Issue date: 1994 Nov 15
- Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
- Authors: Muench MO, Schneider JG, Moore MA
- Issue date: 1992 Mar
- Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.
- Authors: Davis TA, Robinson DH, Lee KP, Kessler SW
- Issue date: 1995 Apr 1
- The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancer.
- Authors: Gheilmini M, Pettengell R, Coutinho LH, Testa N, Crowther D
- Issue date: 1996 Apr